eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.80
-0.82 (-9.51%)
At close: Jun 9, 2026, 4:00 PM EDT
8.30
+0.50 (6.41%)
After-hours: Jun 9, 2026, 6:48 PM EDT
eXoZymes Employees
eXoZymes had 32 employees as of December 31, 2025. The number of employees increased by 1 or 3.23% compared to the previous year.
Employees
32
Change (1Y)
1
Growth (1Y)
3.23%
Revenue / Employee
n/a
Profits / Employee
-$302,268
Market Cap
66.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32 | 1 | 3.23% |
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Adicet Bio | 102 |
| XBiotech | 87 |
| Aardvark Therapeutics | 40 |
| NeurAxis | 24 |
| LeonaBio | 19 |
| Atara Biotherapeutics | 14 |
| MAIA Biotechnology | 13 |
EXOZ News
- 1 day ago - eXoZymes prices 592,270 shares at $18.00 in public offering - TheFly
- 1 day ago - eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - Accesswire
- 26 days ago - eXoZymes Quarterly report: Q1 2026 - Filings
- 4 weeks ago - eXoZymes announces graduation from Shell GameChanger Accelerator - TheFly
- 4 weeks ago - eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program - Accesswire
- 4 weeks ago - eXoZymes Slides: Investor presentation - Filings
- 2 months ago - eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast - Accesswire
- 2 months ago - eXoZymes Slides: Investor presentation - Filings